Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.2400
-0.0010 (-0.41%)
Sep 18, 2026, 5:17 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €10.74 million as of September 18, 2026. Its market cap has decreased by -20.00% in one year.
Market Cap
10.74M
Enterprise Value
9.03M
Revenue
21.00K
Ranking
n/a
PE Ratio
13.33
Stock Price
€0.24
ChartMarket Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 10.74M, a decrease of -89.47%. That is a compound annual growth rate of -15.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 10.74M | 41.18% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 53.07B |
| UCB SA | 39.77B |
| Financière de Tubize | 7.91B |
| Onward Medical | 194.68M |
| Hyloris Pharmaceuticals | 118.16M |
| European Medical Solutions | 17.10M |
| BioSenic | 1.31M |
| Oxurion NV | 394.06K |